跳至主要内容
临床试验/CTRI/2023/04/051304
CTRI/2023/04/051304招募中Unknown

Single-arm clinical study to evaluate the analgesic effect of Trailokya Vijaya Vati Plus (Formulation femme) in Primary Dysmenorrhea.

Amrita School of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Subjects with regular menstrual periods lasting
  • 21 to 35 days and menstruation lasting for 3 to
  • 2. Subjects who give consent for the study.
  • 3. Other causes of pain excluded using USG.
  • 4. Screened Subjects will be assessed by:Clinical
  • history and physical examination,
  • Haematological: Hb,ESR, CBC, Serum SGOT, SGPT &
  • Serum BUN and Creatinine within 1.5 times the
  • upper limit of normal range detected at
  • screening, Urine analysis and USG.

排除标准

  • 1. Subjects having Dysmenorrhea secondary to
  • organic pathologies
  • 2. Subjects with irregular menstrual bleeding
  • 3. Subjects having a severe gynaecological illness
  • like uterine pathology fibroid adenomyosis
  • endometriosis etc
  • 4. Subjects with autoimmune diseases gynaecological Surgeries and genitourinary infections
  • 5. Subjects under hormonal therapy
  • 6. History or documentation of chronic illnesses
  • eg Diabetes hypertension Hypothyroidism bronchial asthma Gastroesophageal Reflux
  • Disease GERD atopic dermatitis celiac
  • disease or gluten sensitivity Crohns Disease
  • ulcerative colitis eating disorders breast
  • cancer a blood disorder
  • 7. History of alcohol drug abuse or cigarette
  • 8. Subjects participating in another investigational drug trial or had participated in one within 30 days of the start of the trial intervention
  • 9. The subject participated in another investigational drug trial in the previous 30 days
  • 10. Mentally retarded patients
  • 11. Any other medical condition which in the
  • opinion of the investigator precludes the
  • inclusion of participant

研究者

发起方
Amrita School of Ayurveda

相似试验